cafepharma

     

Found pages about cafepharma

Tweets about cafepharma

  • China Approves Emergency Ebola Tests Just in Case: Wallstreet OTC Sunday, November 30, 2014 - 10:18am
  • Patients Feel The Pinch Of Higher Generic Drug Prices: CBS Sunday, November 30, 2014 - 10:21am
  • Fresenius set to walk away from Danone unit - sources: Reuters Saturday, November 29, 2014 - 12:56pm
  • GlaxoSmithKline Said to Plan Reorganization, U.S. Cuts: Bloomberg Saturday, November 29, 2014 - 11:11pm
  • The Matthew DeFede, SFR Daily is out! Stories via @cafepharma @HeavySan
  • Plethora Solutions in License Talks For Drug to Rival Viagra Sales: Bloomberg Saturday, November 29, 2014 - 12:42pm
  • Italy Suspends Batches of Novartis Flu Vaccine After 3 Deaths: Bloomberg Saturday, November 29, 2014 - 12:43pm
  • FDA Approves New Noninvasive Technology To Assess Heart Vessels: Forbes Saturday, November 29, 2014 - 12:49pm
  • Diabetes: The Global Epidemic Pushing Novo Nordisk Higher: Seeking Alpha Saturday, November 29, 2014 - 12:37pm
  • “@cafepharma: Novartis says heart-failure drug wins faster review in Europe. #GameChanger #heartfailure #pharma #business
  • Gilead Sciences: New Prescriptions for Hepatitis C Drugs Slow: Barron's Saturday, November 29, 2014 - 10:27am
  • Newly Profitable Medivation Riding High On Drug Sales: Saturday, November 29, 2014 - 10:28am
  • Novartis says heart-failure drug wins faster review in Europe: Yahoo/Reuters Saturday, November 29, 2014 - 10:30am
  • Pfizer deal probably 'would have fallen apart': AZ CEO: CNBC Saturday, November 29, 2014 - 10:25am
  • Senior Sales Representative US
  • @Deany_Smith @GinaRhonj @jackmcdonnel9 @WhorableHWives @Neener25 amber used it in the cafepharma blog too I think
  • Outside Sales US-California-San Bernardino/Palm Springs
  • @cafepharma #Invisiblearmy
  • FDA rejects Avanir's migraine drug-device: Yahoo/Reuters Wednesday, November 26, 2014 - 11:33pm
  • FDA rejects Avanir's migraine drug-device via Latest Headlines from Cafepharma - Yahoo/Reuters ...
  • "@cafepharma: Will #Insulin #Pricing Be MannKind Corporation's Downfall?
  • Hologic Produces the First FDA-Approved 3D Mammography Platform: Yahoo/GuruFocus Wednesday, November 26, 2014 -…
  • Medtronic gets U.S. antitrust OK to buy Covidien with divestiture: Yahoo/Reuters Wednesday, November 26, 2014 -…
  • Will Insulin Pricing Be MannKind Corporation's Downfall?: Motley Fool Wednesday, November 26, 2014 - 12:11pm
  • Via cafepharma: Valeant adds to dermatology portfolio: Medical Marketing and Media Wednesday, November 26, 2014 ...
  • Vivus awarded two patents for Qsymia: Seeking Alpha Wednesday, November 26, 2014 - 12:05pm
  • FDA declines to approve Bristol-Myers hepatitis drug: Yahoo/Reuters Wednesday, November 26, 2014 - 12:08pm
  • Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push: Fierce Pharma Marketing Wednesday,…
  • Valeant adds to dermatology portfolio: Medical Marketing and Media Wednesday, November 26, 2014 - 12:02pm
  • Will Insulin Pricing Be MannKind Corporation's Downfall? via Latest Headlines from Cafepharma - ...
  • Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown: Fierce Biotech Wednesday,…
  • Who are the stars of personalized medicine? Roche, Novartis and J&J: Fierce Pharma Marketing Wednesday, November…
  • Should Drug Makers be Required to Take FDA Advice on Pivotal Trials?: WSJ Pharmalot Wednesday, November 26, 2014 -…
  • Ackman's Pershing Square still holds 26.6 million Allergan shares: Yahoo/Reuters Wednesday, November 26, 2014 -…
  • RT @cafepharma: Bayer Said to Explore Sale of $2.5 Billion Diabetes Bloomberg
  • @cafepharma HOW TO AWAY FROM DIABETED ? & SAY GOOD BYE DIABETES
  • FDA declines to approve Bristol-Myers hepatitis drug via Latest Headlines from Cafepharma - ...
  • Valeant adds to dermatology portfolio via Latest Headlines from Cafepharma - Medical Marketing and ...
  • Vivus awarded two patents for Qsymia via Latest Headlines from Cafepharma - Seeking Alpha ...
  • Back for more: Will Pfizer top its AstraZeneca bid? via Latest Headlines from Cafepharma - CNBC ...
  • Back for more: Will Pfizer top its AstraZeneca bid?: CNBC Wednesday, November 26, 2014 - 10:07am
  • J&J hopes third time is the charm for antitumor agent Yondelis: Fierce Biotech Tuesday, November 25, 2014 - 3:53pm
  • Once-weekly Lilly diabetes drug wins EU approval: Yahoo/Reuters Tuesday, November 25, 2014 - 3:19pm
  • Covidien, Medtronic Shareholders Poised for January Vote: Yahoo/TheStreet Tuesday, November 25, 2014 - 1:46pm
  • Ousted Retrophin CEO Sold Stock While Urging Investors to Buy: Tuesday, November 25, 2014 -…
  • Glaxo Said to Sell 2.5 Billion Euros of Bonds as Rates Fall: Bloomberg Tuesday, November 25, 2014 - 1:36pm
  • Biogen’s Tecfidera Label Updated After Rare Brain Infection Case: Bloomberg Tuesday, November 25, 2014 - 1:35pm
  • Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN): Tuesday, November…
  • Ousted Retrophin CEO Sold Stock While Urging Investors to Buy via Latest Headlines from Cafepharma ...
  • Glaxo Said to Sell 2.5 Billion Euros of Bonds as Rates Fall via Latest Headlines from Cafepharma - ...